argenx SE Files November 2024 Report on Form 6-K
Ticker: ARGX · Form: 6-K · Filed: Nov 20, 2024 · CIK: 1697862
Sentiment: neutral
Topics: regulatory-filing, foreign-private-issuer, sec-filing
TL;DR
argenx SE filed a 6-K on Nov 20, 2024, reporting its monthly activities as a foreign private issuer.
AI Summary
On November 20, 2024, argenx SE filed a Form 6-K, reporting its activities for the month of November 2024. The filing is a report of a foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934. The company's principal executive offices are located in Amsterdam, the Netherlands.
Why It Matters
This filing provides an update on argenx SE's regulatory activities as a foreign private issuer, which is important for investors tracking the company's compliance and reporting obligations.
Risk Assessment
Risk Level: low — This filing is a routine report of a foreign private issuer and does not contain significant new financial or operational information that would immediately impact risk.
Key Players & Entities
- argenx SE (company) — Registrant
- 001-38097 (company) — SEC File Number
- 20241120 (date) — Filing Date
FAQ
What type of filing is this Form 6-K?
This Form 6-K is a Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 Under the Securities Exchange Act of 1934.
When was this Form 6-K filed?
This Form 6-K was filed on November 20, 2024.
What is the company's SEC File Number?
The company's SEC File Number is 001-38097.
Where are argenx SE's principal executive offices located?
argenx SE's principal executive offices are located at Laarderhoogtweg 25, 1101 EB Amsterdam, the Netherlands.
Does argenx SE file annual reports under Form 20-F or Form 40-F?
argenx SE indicates that it files annual reports under cover of Form 20-F.
Filing Stats: 290 words · 1 min read · ~1 pages · Grade level 13.6 · Accepted 2024-11-20 06:35:55
Filing Documents
- tm2428886d1_6k.htm (6-K) — 11KB
- tm2428886d1_ex99-1.htm (EX-99.1) — 16KB
- 0001104659-24-120839.txt ( ) — 28KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. ARGENX SE Date: November 20, 2024 By: /s/ Hemamalini (Malini) Moorthy Name: Hemamalini (Malini) Moorthy Title: General Counsel